+1 347 708 0418
This report studies the T-Cell Therapy market, covering market size for segment by type (CAR-T, TCR, etc.), by application (Hematologic Malignancies, Solid Tumors, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AbbVie, Adaptimmune, Altor Bioscience, Amgen, Bluebird Bio, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for T-Cell Therapy from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the T-Cell Therapy market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of T-Cell Therapy including:
AbbVie
Adaptimmune
Altor Bioscience
Amgen
Bluebird Bio
Celgene Corporation
Cellectis
DiaCarta
Fate Therapeutics
Gilead Sciences
Juno Therapeutics
Kite Pharma
Merck
Novartis
Pfizer
Sorrento Therapeutics
Takara Bio
TCR2 Therapeutics
Unum Therapeutics
Market split by Type, can be divided into:
CAR-T
TCR
TIL Therapies
Market split by Application, can be divided into:
Hematologic Malignancies
Solid Tumors
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 T-Cell Therapy Market Overview
1.1 T-Cell Therapy Definition
1.2 Global T-Cell Therapy Market Size Status and Outlook (2016-2030)
1.3 Global T-Cell Therapy Market Size Comparison by Region (2016-2030)
1.4 Global T-Cell Therapy Market Size Comparison by Type (2016-2030)
1.5 Global T-Cell Therapy Market Size Comparison by Application (2016-2030)
1.6 Global T-Cell Therapy Market Size Comparison by Sales Channel (2016-2030)
1.7 T-Cell Therapy Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 T-Cell Therapy Market Segment Analysis by Player
2.1 Global T-Cell Therapy Sales and Market Share by Player (2019-2021)
2.2 Global T-Cell Therapy Revenue and Market Share by Player (2019-2021)
2.3 Global T-Cell Therapy Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 T-Cell Therapy Market Segment Analysis by Type
3.1 Global T-Cell Therapy Market by Type
3.1.1 CAR-T
3.1.2 TCR
3.1.3 TIL Therapies
3.2 Global T-Cell Therapy Sales and Market Share by Type (2016-2021)
3.3 Global T-Cell Therapy Revenue and Market Share by Type (2016-2021)
3.4 Global T-Cell Therapy Average Price by Type (2016-2021)
3.5 Leading Players of T-Cell Therapy by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 T-Cell Therapy Market Segment Analysis by Application
4.1 Global T-Cell Therapy Market by Application
4.1.1 Hematologic Malignancies
4.1.2 Solid Tumors
4.1.3 Others
4.2 Global T-Cell Therapy Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of T-Cell Therapy by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 T-Cell Therapy Market Segment Analysis by Sales Channel
5.1 Global T-Cell Therapy Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global T-Cell Therapy Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of T-Cell Therapy by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 T-Cell Therapy Market Segment Analysis by Region
6.1 Global T-Cell Therapy Market Size and CAGR by Region (2016-2030)
6.2 Global T-Cell Therapy Sales and Market Share by Region (2016-2021)
6.3 Global T-Cell Therapy Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America T-Cell Therapy Market Share by Type
6.4.3 North America T-Cell Therapy Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe T-Cell Therapy Market Share by Type
6.5.3 Europe T-Cell Therapy Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific T-Cell Therapy Market Share by Type
6.6.3 Asia-Pacific T-Cell Therapy Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America T-Cell Therapy Market Share by Type
6.7.3 South America T-Cell Therapy Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa T-Cell Therapy Market Share by Type
6.8.3 Middle East & Africa T-Cell Therapy Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading T-Cell Therapy Players
7.1 AbbVie
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Adaptimmune
7.3 Altor Bioscience
7.4 Amgen
7.5 Bluebird Bio
7.6 Celgene Corporation
7.7 Cellectis
7.8 DiaCarta
7.9 Fate Therapeutics
7.10 Gilead Sciences
7.11 Juno Therapeutics
7.12 Kite Pharma
7.13 Merck
7.14 Novartis
7.15 Pfizer
7.16 Sorrento Therapeutics
7.17 Takara Bio
7.18 TCR2 Therapeutics
7.19 Unum Therapeutics
Chapter 8 Upstream and Downstream Analysis of T-Cell Therapy
8.1 Industrial Chain of T-Cell Therapy
8.2 Upstream of T-Cell Therapy
8.3 Downstream of T-Cell Therapy
Chapter 9 Development Trend of T-Cell Therapy (2022-2030)
9.1 Global T-Cell Therapy Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global T-Cell Therapy Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global T-Cell Therapy Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global T-Cell Therapy Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global T-Cell Therapy Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure T-Cell Therapy Example
Figure Global T-Cell Therapy Revenue (Million $) Status and Outlook (2016-2030)
Figure Global T-Cell Therapy Revenue (Million $) Comparison by Region (2016-2030)
Figure Global T-Cell Therapy Revenue (Million $) Comparison by Type (2016-2030)
Figure Global T-Cell Therapy Revenue (Million $) Comparison by Application (2016-2030)
Figure Global T-Cell Therapy Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global T-Cell Therapy Sales by Player (2019-2021)
Table Global T-Cell Therapy Sales Market Share by Player (2019-2021)
Figure Global T-Cell Therapy Sales Market Share by Player in 2021
Table Global T-Cell Therapy Revenue (Million $) by Player (2019-2021)
Table Global T-Cell Therapy Revenue Market Share by Player (2019-2021)
Figure Global T-Cell Therapy Revenue Market Share by Player in 2021
Table Global T-Cell Therapy Average Price by Player (2019-2021)
Figure Global T-Cell Therapy Average Price by Player in 2021
Figure Global T-Cell Therapy Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global T-Cell Therapy Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of CAR-T
Figure Global CAR-T Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of TCR
Figure Global TCR Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of TIL Therapies
Figure Global TIL Therapies Revenue (Million $) and Growth Rate (2016-2021)
Table Global T-Cell Therapy Sales by Type (2016-2021)
Table Global T-Cell Therapy Sales Market Share by Type (2016-2021)
Figure Global T-Cell Therapy Sales Market Share by Type in 2021
Table Global T-Cell Therapy Revenue (Million $) by Type (2016-2021)
Table Global T-Cell Therapy Revenue Market Share by Type (2016-2021)
Figure Global T-Cell Therapy Revenue Market Share by Type in 2021
Table Global T-Cell Therapy Average Price by Type (2016-2021)
Figure Global T-Cell Therapy Average Price by Type in 2021
Table Leading Players of T-Cell Therapy by Type in 2021
Figure Example of Hematologic Malignancies
Figure Global T-Cell Therapy for Hematologic Malignancies Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Solid Tumors
Figure Global T-Cell Therapy for Solid Tumors Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global T-Cell Therapy for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global T-Cell Therapy Sales by Application (2016-2021)
Table Global T-Cell Therapy Sales Market Share by Application (2016-2021)
Figure Global T-Cell Therapy Sales Market Share by Application in 2021
Table Leading Consumers of T-Cell Therapy by Application in 2021
Figure Example of Direct Channel
Figure Global T-Cell Therapy for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global T-Cell Therapy for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global T-Cell Therapy Revenue by Sales Channel (2016-2021)
Table Global T-Cell Therapy Revenue Market Share by Sales Channel (2016-2021)
Figure Global T-Cell Therapy Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of T-Cell Therapy by Sales Channel in 2021
Table Global T-Cell Therapy Market Size and CAGR by Region (2016-2030)
Table Global T-Cell Therapy Sales by Region (2016-2021)
Table Global T-Cell Therapy Sales Market Share by Region (2016-2021)
Figure Global T-Cell Therapy Sales Market Share by Region in 2021
Table Global T-Cell Therapy Revenue (Million $) by Region (2016-2021)
Table Global T-Cell Therapy Revenue Market Share by Region (2016-2021)
Figure Global T-Cell Therapy Revenue Market Share by Region in 2021
Table North America T-Cell Therapy Sales by Country (2016-2021)
Figure North America T-Cell Therapy Sales Market Share by Country (2016-2021)
Table North America T-Cell Therapy Revenue by Country (2016-2021)
Figure North America T-Cell Therapy Revenue Market Share by Country (2016-2021)
Figure North America T-Cell Therapy Market Share by Type in 2021
Figure North America T-Cell Therapy Market Share by Application in 2021
Figure United States T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure United States T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Canada T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Mexico T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Table Europe T-Cell Therapy Sales by Country (2016-2021)
Figure Europe T-Cell Therapy Sales Market Share by Country (2016-2021)
Table Europe T-Cell Therapy Revenue by Country (2016-2021)
Figure Europe T-Cell Therapy Revenue Market Share by Country (2016-2021)
Figure Europe T-Cell Therapy Market Share by Type in 2021
Figure Europe T-Cell Therapy Market Share by Application in 2021
Figure Germany T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Germany T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure UK T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure UK T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure France T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure France T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Italy T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Russia T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Spain T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific T-Cell Therapy Sales by Country (2016-2021)
Figure Asia-Pacific T-Cell Therapy Sales Market Share by Country (2016-2021)
Table Asia-Pacific T-Cell Therapy Revenue by Country (2016-2021)
Figure Asia-Pacific T-Cell Therapy Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific T-Cell Therapy Market Share by Type in 2021
Figure Asia-Pacific T-Cell Therapy Market Share by Application in 2021
Figure China T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure China T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Japan T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Korea T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure India T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure India T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Southeast Asia T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Australia T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Table South America T-Cell Therapy Sales by Country (2016-2021)
Figure South America T-Cell Therapy Sales Market Share by Country (2016-2021)
Table South America T-Cell Therapy Revenue by Country (2016-2021)
Figure South America T-Cell Therapy Revenue Market Share by Country (2016-2021)
Figure South America T-Cell Therapy Market Share by Type in 2021
Figure South America T-Cell Therapy Market Share by Application in 2021
Figure Brazil T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Brazil T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Argentina T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Colombia T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa T-Cell Therapy Sales by Country (2016-2021)
Figure Middle East & Africa T-Cell Therapy Sales Market Share by Country (2016-2021)
Table Middle East & Africa T-Cell Therapy Revenue by Country (2016-2021)
Figure Middle East & Africa T-Cell Therapy Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa T-Cell Therapy Market Share by Type in 2021
Figure Middle East & Africa T-Cell Therapy Market Share by Application in 2021
Figure UAE T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure UAE T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure Saudi Arabia T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa T-Cell Therapy Sales and Growth Rate (2016-2021)
Figure South Africa T-Cell Therapy Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of AbbVie
Table T-Cell Therapy Introduction of AbbVie
Table T-Cell Therapy Sales, Price, Revenue, Gross Margin and Market Share of AbbVie (2019-2021)
Table Industrial Chain of T-Cell Therapy
Table Manufacturing Cost Structure of T-Cell Therapy
Table General Manufacturing Process of T-Cell Therapy
Table Leading Distributors/Dealers of T-Cell Therapy
Table Leading Consumers of T-Cell Therapy
Figure Global T-Cell Therapy Sales and Growth Rate Forecast (2022-2030)
Figure Global T-Cell Therapy Revenue and Growth Rate Forecast (2022-2030)
Table Global T-Cell Therapy Market Size and CAGR Forecast by Region (2022-2030)
Table Global T-Cell Therapy Market Size and CAGR Forecast by Type (2022-2030)
Table Global T-Cell Therapy Market Size and CAGR Forecast by Application (2022-2030)
Table Global T-Cell Therapy Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
